Oramed Pharmaceuticals (ORMP)Rep. Andrew Garbarino (NY02) disclosed a partial sale $1K–$15K
Rep. Andrew Garbarino (NY02) disclosed a partial sale of Oramed Pharmaceuticals in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 33 days
- Disclosure lag
- Traded
- Oct 1, 2021
- Disclosed
- Nov 3, 2021
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 1, 2021 · this disclosureCongressDisclosed partial sale of ORMP — reported range $1,001 - $15,000
What came next
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Oramed Pharmaceuticals
For Oramed Pharmaceuticals, OQRO holds 2 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ORMP page.
Other recent filings by Rep. Andrew Garbarino (NY02)
- House Clerk periodic transaction report at Gap Inc. (GAP)Aug 21, 2025
- House Clerk periodic transaction report at Oramed Pharmaceuticals (ORMP)Jan 14, 2022
- House Clerk periodic transaction report at OneSpaWorld Holdings Limited (OSW)Nov 3, 2021
- House Clerk periodic transaction report at OneSpaWorld Holdings Limited (OSW)May 24, 2021
- House Clerk periodic transaction report at Oramed Pharmaceuticals (ORMP)May 24, 2021
The full history of Rep. Andrew Garbarino (NY02) is on the profile page.
How this filing works
Other disclosures at Oramed Pharmaceuticals
- SEC Form 4Oct 2, 2026
- SEC Form 4Oct 2, 2026
- SEC Form 4Jul 2, 2026
- SEC Form 4Jul 2, 2026
- House Clerk periodic transaction reportFeb 25, 2025
- House Clerk periodic transaction reportJan 14, 2022
Everything OQRO holds on this company is on its ORMP page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data